comparemela.com
Home
Live Updates
E Opgn Us68373l4068 - Breaking News
Pages:
Latest Breaking News On - E opgn us68373l4068 - Page 1 : comparemela.com
OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Total revenue for 2022 was approximately $2.6 millionBalance sheet strengthened by recently closed public offering with gross proceeds of $7.5 millionConference call to be held March. | March 29, 2023
Curetis gmb
Oliver schacht
Albert weber
Gene panel
International number
Foundation for innovative new diagnostics
European investment bank
Securities exchange
Opgen investor press contact
Technology platform
Opgen inc
Exchange commission
Edison group
Full year
Chief financial officer
Beijing clear biotech
vimarsana © 2020. All Rights Reserved.